Conditioned medium from horse amniotic membrane-derived multipotent progenitor cells: Immunomodulatory activity in vitro and first clinical application in tendon and ligament injuries in vivo

Stem Cells and Development

Volumn 22, Issue 22, 2013, Pages 3015-3024

  Lange Consiglio, Anna ^a   Rossi, Daniele ^b   Tassan, Stefano ^c   Perego, Roberta ^a   Cremonesi, Fausto ^a,d   Parolini, Ornella ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Istituto Ospedaliero   (Italy)

^c Private Practitioner   (Italy)

^d Department of Veterinary Science for Animal Health Production and Food Safety   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMNION; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL PROLIFERATION; FEMALE; HORSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LIGAMENT INJURY; LYMPHOCYTE PROLIFERATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TENDON INJURY; TENDON RECONSTRUCTION; THERAPY EFFECT;

AMNION; ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; FEMALE; HORSES; IMMUNOMODULATION; LEUKOCYTES, MONONUCLEAR; LIGAMENTS; MESENCHYMAL STROMAL CELLS; MULTIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; TENDON INJURIES; TENDONS;

EID: 84888023834     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0214     Document Type: Article

References (46)

1. Salingcarnboriboon R, H Yoshitake, K Tsuji, M Obinata, T Amagasa, A Nifuji and M Noda. (2003). Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res 287:289-300.
2. Seo BM, M Miura, S Gronthos, PM Bartold, S Batouli, J Brahim, M Young, PG Robey, CY Wang and S Shi. (2004). Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364:149-155.
3. Bi Y, D Ehirchiou, TM Kilts, CA Inkson, MC Embree, W Sonoyama, L Li, AI Leet, BM Seo, et al. (2007). Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 13:1219-1227.
4. de Mos M, WJ Koevoet, H Jahr, MM Verstegen, MP Heijboer, N Kops, JP van Leeuwen, H Weinans, JA Verhaar and GJ van Osch. (2007). Intrinsic differentiation potential of adolescent human tendon tissue: an in-vitro cell differentiation study. BMC Musculoskelet Disord 8:16.
5. Lovati AB, B Corradetti, A Lange Consiglio, C Recordati, E Bonacina, D Bizzaro and F Cremonesi. (2011). Characterization and differentiation of equine tendon-derived progenitor cells. J Biol Regul Homeost Agents 25(2 Suppl): S75-S84.
6. Hertel D. (2001). Enhanced suspensory ligament healing in 100 horses by stem cells and other bone marrow components. Proc Am Assoc Equine Pract 47:319-321.
7. Fortier LA and RK Smith. (2008). Regenerative medicine for tendinous and ligamentous injuries of sport horses. Vet Clin North Am Equine Pract 24:191-201.
8. Lange-Consiglio A, B Corradetti, A Meucci, D Bizzaro and F Cremonesi. (2013). Characteristics of equine mesenchymal stem cells derived from amnion and bone marrow: in vitro proliferative and multilineage potential assessment. Equine Vet J [Epub ahead of print]; DOI: 10.1111/evj.12052.
9. Guest DJ, MR Smith and WR Allen. (2010). Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Equine Vet J 42:636-642.
10. Lange-Consiglio A, B Corradetti, D Bizzaro, M Magatti, L Ressel, S Tassan, O Parolini and F Cremonesi. (2012). Characterization and potential applications of progenitorlike cells isolated from horse amniotic membrane. J Tissue Eng Regen Med 6:622-635.
11. Lange-Consiglio A, S Tassan, B Corradetti, A Meucci, R Perego, D Bizzaro and F Cremonesi. (2013). Investigating the potential of equine mesenchymal stem cells derived from amnion and bone marrow in equine tendon diseases treatment in vivo. Cytotherapy [Epub ahead of print]; DOI:10.1016/j.jcyt.2013.03.002.
12. Barboni B, V Russo, V Curini, A Mauro, A Martelli, A Muttini, N Bernabò, L Valbonetti, M Marchisio, et al. (2012). Achilles tendon regeneration can be improved by amniotic epithelial cell allotransplantation. Cell Transplant 21:2377-2395.
13. Muttini A, L Valbonetti, M Abate, A Colosimo, V Curini, A Mauro, P Berardinelli, V Russo, D Cocciolone, et al. (2013). Ovine amniotic epithelial cells: in vitro characterization and transplantation into equine superficial digital flexor tendon spontaneous defects. Res Vet Sci 94:158-169.
14. Richardson LE, J Dudhia, PD Clegg and R Smith. (2007). Stem cells in veterinary medicine-attempts at regenerating equine tendon after injury. Trends Biotechnol 25:409-416.
15. Chong AK, J Chang and JC Go. (2009). Mesenchymal stem cells and tendon healing. Front Biosci 14:4598-4605.
16. Yagi H, A Soto-Gutierrez, B Parekkadan, Y Kitagawa, RG Tompkins, N Kobayashi and ML Yarmush. (2010). Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 19:667-679.
17. Fortier LA and AJ Travis. (2011). Stem cells in veterinary medicine. Stem Cell Res Ther 2:9.
18. Dahlgren LA, MC van der Meulen, JE Bertram, GS Starrak and AJ Nixon. (2002). Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenaseinduced model of flexor tendinitis. J Orthop Res 20:910-919.
19. Schnabel LV, ME Lynch, MC van der Meulen, AE Yeager, MA Kornatowski and AJ Nixon. (2009). Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J Orthop Res 27:1392-1398.
20. Magatti M, S De Munari, E Vertua, L Gibelli, G Wengler and O Parolini. (2008). Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 26:182-192.
21. Ren G, L Zhang, X Zhao, G Xu, Y Zhang, AI Roberts, RC Zhao and Y Shi. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2:141-150.
22. Herrero C and JA Pérez-Simón. (2010). Immunomodulatory effect of mesenchymal stem cells. Braz J Med Biol Res 43:425-430.
23. Rantanen NW. (2003). Ultrasonographic evaluation of the equine limb: technique. In: Diagnosis and Management of Lameness in the Horse. Ross MW and Dyson SJ, eds. Philadelphia, WB Saunders. pp. 66-67.
24. Werpy N, L Farrington and D Frisbie. (2011). How to Perform Radiographic-Guided Needle Placement Into the Collateral Ligaments of the Distal Interphalangel Joint. Proceedings of the AAEP Annual Convention, San Antonio, TX, November 18-22.
25. Dyson SJ. (2004). Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992- 2000). Equine Vet J 36:415-419.
26. Smith RK and PM Webbon. (2005). Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn? Br J Sports Med 39:582-584.
27. Smith RK. (2008). Mesenchymal stem cell therapy for equine tendinopathy. Disabil Rehabil 30:1752-1758.
28. Carrade DD, MW Lame, MS Kent, KC Clark, NJ Walker and DL Borjesson. (2012). Comparative analysis of the immunomodulatory properties of equine adult-derived mesenchymal stem cells. Cell Med 4:1-11.
29. Bailo M, M Soncini, E Vertua, PB Signoroni, S Sanzone, G Lombardi, D Arienti, F Calamani, D Zatti, et al. (2004). Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78:1439-1448.
30. Wolbank S, A Peterbauer, M Fahrner, S Hennerbichler, M van Griensven, G Stadler, H Redl and C Gabriel. (2007). Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13:1173-1183.
31. Rossi D, S Pianta, M Magatti, P Sedlmayr and O Parolini. (2012). Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PLoS One 7:e46956.
32. Engela AU, CC Baan, FJ Dor, W Weimar and MJ Hoogduijn. (2012). On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation. Front Immunol 3:126.
33. Nauta AJ and WE Fibbe. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506.
34. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822.
35. Chabannes D, M Hill, E Merieau, J Rossignol, R Brion, JP Soulillou, I Anegon and MC Cuturi. (2007). A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110:3691-3694.
36. Selmani Z, A Naji, I Zidi, B Favier, E Gaiffe, L Obert, C Borg, P Saas, P Tiberghien, et al. (2008). Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 + CD25highFOXP3 + regulatory T cells. Stem Cells 26:212-222.
37. Timmers L, SK Lim, F Arslan, JS Armstrong, IE Hoefer, PA Doevendans, JJ Piek, RM El Oakley, A Choo, et al. (2007). Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1:129-137.
38. van Poll D, B Parekkadan, CH Cho, F Berthiaume, Y Nahmias, AW Tilles and ML Yarmush. (2008). Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47:1634-1643.
39. Di Santo S, Z Yang, M Wyler von Ballmoos, J Voelzmann, N Diehm, I Baumgartner and C Kalka. (2009). Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 4:e5643.
40. Cargnoni A, L Gibelli, A Tosini, P Signoroni, C Nassuato, D Arienti, G Lombardi, A Albertini, G Wengler and O Parolini. (2009). Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 18:405-422.
41. Cargnoni A, L Ressel, D Rossi, A Poli, D Arienti, G Lombardi and O Parolini. (2012). Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis. Cytotherapy 14: 153-161.
42. Bosch G, M Moleman, A Barneveld, PR van Weeren and HTM van Schie. (2011). The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions. Scand J Med Sci Sports 21:554-561.
43. Meirelles LaS, AM Fontes, DT Covas and AI Caplan. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419-427.
44. Tang YL, Q Zhao, YC Zhang, L Cheng, M Liu, J Shi, YZ Yang, C Pan, J Ge and MI Phillips. (2004). Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117:3-10.
45. Godwin EE, NJ Young, J Dudhia, IC Beamish and RKW Smith. (2012). Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J 44:25-32.
46. Crevier-Denoix N, P Pourcelot, D Erlinger, D Concordet, C Lagache, A Ricard, L Tavernier and JM Denoix. (2005). Comparison of the comformation of 20 international level and the 20 low level jumping horses using a 3-D video morphometric measurement method. Anat Histol Embryol 34:suppl s1, 13.